Citadel Advisors »

Qualigen Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Qualigen Therapeutics (QLGN) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Qualigen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Qualigen Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Qualigen Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 154k 0.17
2024-03-31 $22k 57k 0.39
2023-12-31 $19k 35k 0.55

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Qualigen Therapeutics

Citadel Advisors
Hrt Financial
Geode Capital Management
BlackRock
BlackRock
Vanguard Group
Virtu Financial
Two Sigma Securities
Northern Trust
State Street Corporation
Jump Financial
HighMark Wealth Management
Tower Research Capital
Bank of America Corporation
Us Bancorp

View all funds holding Qualigen Therapeutics